BOSTON (AP) — BOSTON (AP) — Pieris Pharmaceuticals Inc. (PIRS) on Wednesday reported a loss of $13.2 million in its first quarter.

The Boston-based company said it had a loss of 18 cents per share.

The biopharmaceutical company posted revenue of $1.9 million in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PIRS at https://www.zacks.com/ap/PIRS

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News